Healthcare provider profile · identity verified

Trent D Thompson, MD

Family Practice · WAUNAKEE, WI · NPI 1831144401

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	742	199
Lisinopril	Lisinopril	377	95
Omeprazole	Omeprazole	303	86
Amlodipine Besylate	Amlodipine Besylate	241	64
Levothyroxine Sodium	Levothyroxine Sodium	231	52
Hydrochlorothiazide	Hydrochlorothiazide	227	72
Metoprolol Succinate	Metoprolol Succinate	203	57
Simvastatin	Simvastatin	182	44
Losartan Potassium	Losartan Potassium	176	52
Rosuvastatin Calcium	Rosuvastatin Calcium	152	39
Tamsulosin Hcl	Tamsulosin Hcl	149	41
Metformin Hcl Er	Metformin Hcl	141	38
Furosemide	Furosemide	132	31
Sertraline Hcl	Sertraline Hcl	128	30
Eliquis	Apixaban	120	28
Metformin Hcl	Metformin Hcl	114	27
Metoprolol Tartrate	Metoprolol Tartrate	112	31
Finasteride	Finasteride	92	25
Ozempic	Semaglutide	90	12
Gabapentin	Gabapentin	81	32
Atenolol	Atenolol	80	20
Glimepiride	Glimepiride	77	19
Pantoprazole Sodium	Pantoprazole Sodium	75	21
Allopurinol	Allopurinol	73	17
Fluticasone Propionate	Fluticasone Propionate	73	33
Xarelto	Rivaroxaban	73	14
Carvedilol	Carvedilol	69	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	suppressed
Clopidogrel	Clopidogrel Bisulfate	59	18
Warfarin Sodium	Warfarin Sodium	59	11
Escitalopram Oxalate	Escitalopram Oxalate	56	14
Trazodone Hcl	Trazodone Hcl	55	15
Albuterol Sulfate Hfa	Albuterol Sulfate	53	25
Mirtazapine	Mirtazapine	51	suppressed
Jardiance	Empagliflozin	50	12
Triamcinolone Acetonide	Triamcinolone Acetonide	49	29
Fluoxetine Hcl	Fluoxetine Hcl	48	15
Alendronate Sodium	Alendronate Sodium	46	suppressed
Potassium Chloride	Potassium Chloride	46	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	17
Prednisone	Prednisone	44	24
Chlorthalidone	Chlorthalidone	40	14
Benazepril Hcl	Benazepril Hcl	39	11
Bupropion Xl	Bupropion Hcl	39	suppressed
Famotidine	Famotidine	39	suppressed
Enalapril Maleate	Enalapril Maleate	38	11
Hydroxyzine Hcl	Hydroxyzine Hcl	38	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	35	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Cephalexin	Cephalexin	30	19
Ezetimibe	Ezetimibe	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	17
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Terazosin Hcl	Terazosin Hcl	29	suppressed
Amoxicillin	Amoxicillin	28	20
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Nitroglycerin	Nitroglycerin	27	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	21
Digoxin	Digoxin	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	11
Tramadol Hcl	Tramadol Hcl	23	suppressed
Azithromycin	Azithromycin	22	22
Glipizide	Glipizide	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	16
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Lovastatin	Lovastatin	19	suppressed
Naproxen	Naproxen	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Lorazepam	Lorazepam	14	11
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Lithium Carbonate Er	Lithium Carbonate	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Colchicine	Colchicine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Temazepam	Temazepam	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nystatin	Nystatin	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error